 |
double stranded oligomer AD00370 RNA interference-based liver targeted therapeutic |
|---|---|
| Trade Name | |
| Orphan Indication | Alpha-1 antitrypsin deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-09 00:00:00 |
| Sponsor | Arrowhead Research Corporation;225 South Lake Avenue, Suite 1050;Pasadena, California, 91101 |
